Related Experiment Video
Updated: Aug 6, 2026
10:35
Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Glucose Transporter 1 in Health and Disease
Yi Tai1,2, Zhihao Chen3, Yuping Zhu1,2
1Department of Colorectal Surgery Zhejiang Cancer Hospital Hangzhou China.
Medcomm
|July 24, 2026
Summary
Glucose Transporter 1 (GLUT1) fuels cancer growth and immune evasion. Novel precision therapies targeting GLUT1 offer a promising strategy for effective immuno-oncology with reduced toxicity.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Background:
- Glucose Transporter 1 (GLUT1) is crucial for cellular energy, but its dysregulation causes neurological disorders and fuels cancer via the Warburg effect.
- Overexpressed GLUT1 in tumors remodels the tumor microenvironment (TME), promoting metabolic competition, immune exclusion, and therapeutic resistance.
Purpose of the Study:
- To review GLUT1's regulatory networks in health and disease.
- To dissect GLUT1's role in remodeling the TME and driving metabolic immune exclusion.
- To explore emerging precision interventions for GLUT1-targeted immuno-oncology.
Main Methods:
- Comprehensive literature review of GLUT1's role in cellular metabolism, disease pathogenesis, and TME.
- Analysis of GLUT1-driven metabolic competition and its impact on immune exclusion.
- Evaluation of novel therapeutic strategies including nanocarriers, PROTACs, and engineered CAR-T cells.
Main Results:
- GLUT1 overexpression fundamentally alters the TME, fostering metabolic competition that leads to immune exclusion and treatment resistance.
- Emerging precision interventions show potential to overcome limitations of traditional systemic GLUT1 inhibition.
- Targeting GLUT1 as a linchpin of the immunosuppressive ecosystem is key for precision metabolic immuno-oncology.
Conclusions:
- GLUT1 is a central regulator of metabolic adaptation in cancer, driving immunosuppression and therapeutic resistance.
- Precision strategies like glycan-nanocarriers, PROTACs, and metabolic CAR-T cells offer a roadmap for effective immuno-oncology.
- Targeting GLUT1 enables development of therapies with durable efficacy and minimized collateral damage.
Keywords:
Warburg effectglucose homeostasisglucose transporter 1 (GLUT1)targeted therapytumor microenvironment (TME)More Related Videos
07:04Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina
Published on: March 14, 2025
06:28A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016
Related Concept Videos
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:26Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
01:32Secondary Active Transport
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
01:55Secondary Active Transport
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
01:23Transcellular Transport of Solutes
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...